fda warning letters glp-1 october 2025 news Receptor Agonists and vision risk FDA warns telehealth companies over

Even if, in the first couple years of Mounjaro and Wegovy both being approved for the weight loss indication, the impact from just those taking it who can afford it/have the insurance for it can be significant

Read full disclaimer What is the Process for an Online GLP-1 Prescription

doi: 10.3390/jcm10050985 174 UnniSWittbrodtEMaJSchauerhamerMHurdJRuiz-NegrnNet al

261 SpenceJ

The decision is significant for the broader GLP-1 multidistrict litigation, where plaintiffs allege drug manufacturers failed to adequately warn consumers about risks including gastroparesis, bowel obstruction, ileus, and other injuries while aggressively marketing the medications for weight loss